Wolverine Trading’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,628
Closed -$544K 5696
2025
Q2
$544K Sell
3,628
-2,728
-43% -$364K ﹤0.01% 2870
2025
Q1
$989K Sell
6,356
-2,388
-27% -$400K ﹤0.01% 2244
2024
Q4
$1.6M Buy
8,744
+1,903
+28% +$367K ﹤0.01% 2165
2024
Q3
$1.36M Buy
+6,841
New +$1.42M ﹤0.01% 2057
2024
Q1
Sell
-2,595
Closed -$620K 4625
2023
Q4
$613K Buy
+2,595
New +$510K ﹤0.01% 2741
2022
Q4
Sell
-1,733
Closed -$378K 4144
2022
Q3
$329K Buy
+1,733
New +$374K ﹤0.01% 3054
2022
Q2
Sell
-1,263
Closed -$309K 4660
2022
Q1
$366K Sell
1,263
-4,315
-77% -$1.33M ﹤0.01% 3654
2021
Q4
$2.1M Buy
5,578
+2,319
+71% +$901K ﹤0.01% 1843
2021
Q3
$1.38M Sell
3,259
-2,832
-46% -$1.18M ﹤0.01% 2581
2021
Q2
$2.26M Buy
6,091
+2,775
+84% +$927K ﹤0.01% 1862
2021
Q1
$955K Buy
+3,316
New +$922K ﹤0.01% 2818
2020
Q4
Sell
-1,241
Closed -$296K 4883
2020
Q3
$277K Buy
+1,241
New +$258K ﹤0.01% 3487
2020
Q2
Sell
-9,142
Closed -$1.46M 4657
2020
Q1
$1.19M Buy
9,142
+5,933
+185% +$890K ﹤0.01% 1770
2019
Q4
$487K Buy
+3,209
New +$444K ﹤0.01% 3095
2018
Q3
Sell
-2,420
Closed -$258K 5030
2018
Q2
$258K Hold
2,420
﹤0.01% 3997
2018
Q1
$258K Buy
+2,420
New +$261K ﹤0.01% 3997

Other funds holding CRL

Wolverine Trading's CRL Position: Q3 2025 in Review

Wolverine Trading sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 3,628 shares — an estimated $544K sold.

Wolverine Trading first reported a position in CRL in Q1 2018 and held it in 16 quarters. The position peaked at $2.26M in Q2 2021. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Wolverine Trading reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 3,628 Charles River Laboratories shares in Q3 2025, an estimated $544K.
  • Wolverine Trading first reported a position in Charles River Laboratories in Q1 2018 and held it in 16 quarters.
  • Wolverine Trading's Charles River Laboratories position peaked at $2.26M in Q2 2021.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.